Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure.
Komarnicki P, Gut P, Musiałkiewicz J, Cieślewicz M, Maciejewski A, Patel P, Mastorakos G, Ruchała M. Komarnicki P, et al. Among authors: cieslewicz m. Endocr Connect. 2023 Sep 13;12(10):e230249. doi: 10.1530/EC-23-0249. Print 2023 Oct 1. Endocr Connect. 2023. PMID: 37552533 Free PMC article.
Iron Homeostasis and Hepcidin Concentration in Patients With Acromegaly.
Krygier A, Szczepanek-Parulska E, Cieślewicz M, Wrotkowska E, Chanaj-Kaczmarek J, Ruchała M. Krygier A, et al. Among authors: cieslewicz m. Front Endocrinol (Lausanne). 2022 Feb 8;12:788247. doi: 10.3389/fendo.2021.788247. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35211089 Free PMC article.
Clinical, Biochemical, and Sonographic Factors Influencing Performance of Parathormone Washout Measurement vs. 99mTc-MIBI Scintigraphy in the Preoperative Diagnostics of Parathyroid Adenomas.
Szczepanek-Parulska E, Filipowicz D, Czepczyński R, Wietrzyk D, Adamska M, Sawicka-Gutaj N, Cieślewicz M, Bromińska B, Stajgis P, Ruchała M. Szczepanek-Parulska E, et al. Among authors: cieslewicz m. J Clin Med. 2023 Jun 17;12(12):4097. doi: 10.3390/jcm12124097. J Clin Med. 2023. PMID: 37373790 Free PMC article.
Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumors.
Chen JJ, Vincent MY, Shepard D, Peereboom D, Mahalingam D, Battiste J, Patel MR, Juric D, Wen PY, Bullock A, Selfridge JE, Pant S, Liu J, Li W, Fyfe S, Wang S, Zota V, Mahoney J, Watnick RS, Cieslewicz M, Watnick J. Chen JJ, et al. Among authors: cieslewicz m. Commun Med (Lond). 2024 May 21;4(1):95. doi: 10.1038/s43856-024-00520-z. Commun Med (Lond). 2024. PMID: 38773224 Free PMC article.
25 results